William Newman

Directeur/Membre du Conseil chez Virogenomics BioDevelopment, Inc.

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
James Hicks	M	77	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	23 ans
Jeff King	M	-	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	23 ans
Renee Shirley	F	-	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	23 ans
Gilbert N. Miller	M	-	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	-
James W. Korfhage	M	-	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	-
Brock Metcalf	M	-	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	-
Rob Wiltbank	M	-	Virogenomics BioDevelopment, Inc. Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.	-